Daiichi Sankyo (India)

Daiichi Sankyo (India)

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

60%


Total
Publications

302


Total Open
Publications

180


Total
Citations

2.4K


Open Access
Percentage

60%


Total
Publications

302


Total Open
Publications

180


Total
Citations

2.4K

Wikipedia

Website

download

Breakdown

52% 5% 3% 40%

Publisher Open

52%

Both

5%

Other Platform Open

3%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

9%OA Journal

OA Journal 9%

15

Hybrid 13%

23

No Guarantees 78%

134

Other Platform Open

Domain 71%

17

Public 17%

4

Preprint 13%

3

Institution 8%

2

Other Internet 8%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
17
Europe PMC
Domain
15
Semantic Scholar
Public
4
bioRxiv
Preprint
3
Aalborg Universitet - VBN Forskningsportal
Other Internet
2
University of Oxford - Oxford Academic Notes & Queries
Institution
1
Kyushu University - QIR (Kyushu University Institutional Repository)
Institution
1
INFN Catania - INFM-OAR
Other Internet
1
1 / 1

Data updated 25 January 2024

Share

Share

Share